Current diagnostics and treatment of fibrosarcoma -perspectives for future therapeutic targets and strategies-Reference-Cited by-同舟云学术

Current diagnostics and treatment of fibrosarcoma -perspectives for future therapeutic targets and strategies

Published:2017-08-10 Issue:61 Volume:8 Page:104638-104653
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Augsburger Daniela¹,Nelson Peter J.²,Kalinski Thomas³,Udelnow Andrej¹,Knösel Thomas⁴,Hofstetter Monika²,Qin Ji Wei¹,Wang Yan¹,Gupta Arvid Sen¹,Bonifatius Susanne¹,Li Minglun⁵,Bruns Christiane J.¹⁶⁷,Zhao Yue¹⁶⁷

Affiliation:

1. Department of General, Visceral und Vascular Surgery, Otto-von-Guericke University, Magdeburg, Germany

2. Clinical Biochemistry Group, Medizinische Klinik und Poliklinik IV, University of Munich, Munich, Germany

3. Department of Pathology, Otto-von-Guericke University, Magdeburg, Germany

4. Institute of Pathology, Ludwig-Maximilians-University (LMU), Munich, Germany

5. Department of Radiation Oncology, Ludwig-Maximilians-University (LMU), Munich, Germany

6. Department of General, Visceral and Cancer Surgery, University Hospital of Cologne, Cologne, Germany

7. Present address: Department of General, Visceral and Cancer Surgery, University Hospital of Cologne, Cologne, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A thermoresponsive chitosan-based in situ gel formulation incorporated with 5-FU loaded nanoerythrosomes for fibrosarcoma local chemotherapy;International Journal of Biological Macromolecules;2024-10

2. A pan-cancer dye for solid-tumour screening, resection and wound monitoring via short-wave and near-infrared fluorescence imaging;Nature Biomedical Engineering;2024-09-09

3. 3D-printing technology guides precision treatment of recurrent fibrous sarcoma in the abdominal wall;Asian Journal of Surgery;2024-09

4. Stimulator of Interferon Genes-Activated Biomimetic Dendritic Cell Nanovaccine as a Chemotherapeutic Booster to Enhance Systemic Fibrosarcoma Treatment;ACS Nano;2024-08-22

5. Potential of MMP-2 and MMP-9 Gelatinase Blockade as a Therapeutic Strategy in Fibrosarcoma Treatment: A Decadal Review;Targets;2024-06-05